{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,11]],"date-time":"2026-10-11T17:28:42Z","timestamp":1791739722558,"version":"4.3.4"},"reference-count":55,"publisher":"Frontiers Media SA","funder":[{"DOI":"10.13039\/100006492","name":"Division of Intramural Research, National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006492","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"DOI":"10.3389\/fimmu.2017.01867","type":"journal-article","created":{"date-parts":[[2017,12,22]],"date-time":"2017-12-22T05:12:03Z","timestamp":1513919523000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":179,"title":["Chronic Active Epstein\u2013Barr Virus Disease"],"prefix":"10.3389","volume":"8","author":[{"given":"Hiroshi","family":"Kimura","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey I.","family":"Cohen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2017,12,22]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1505","DOI":"10.1086\/491740","article-title":"A prospective clinical study of Epstein-Barr virus and host interactions during acute infectious mononucleosis","volume":"192","author":"Balfour","year":"2005","journal-title":"J Infect Dis"},{"key":"B2","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1146\/annurev-immunol-032414-112326","article-title":"The immunology of Epstein-Barr virus-induced disease","volume":"33","author":"Taylor","year":"2015","journal-title":"Annu Rev Immunol"},{"key":"B3","doi-asserted-by":"publisher","first-page":"1827","DOI":"10.1084\/jem.20161017","article-title":"Two alternate strategies for innate immunity to Epstein-Barr virus: one using NK cells and the other NK cells and \u03b3\u03b4 T cells","volume":"214","author":"Djaoud","year":"2017","journal-title":"J Exp Med"},{"key":"B4","doi-asserted-by":"publisher","first-page":"323","DOI":"10.3389\/fimmu.2016.00323","article-title":"NK cell influence on the outcome of primary Epstein-Barr virus infection","volume":"7","author":"Chijioke","year":"2016","journal-title":"Front Immunol"},{"key":"B5","doi-asserted-by":"publisher","first-page":"8016","DOI":"10.1128\/JVI.00403-07","article-title":"Epstein-Barr virus induces MCP-1 secretion by human monocytes via TLR2","volume":"81","author":"Gaudreault","year":"2007","journal-title":"J Virol"},{"key":"B6","doi-asserted-by":"publisher","first-page":"906","DOI":"10.1038\/nm0896-906","article-title":"Large clonal expansions of CD8+ T cells in acute infectious mononucleosis","volume":"2","author":"Callan","year":"1996","journal-title":"Nat Med"},{"key":"B7","doi-asserted-by":"publisher","first-page":"1251","DOI":"10.1172\/JCI10590","article-title":"CD8(+) T-cell selection, function, and death in the primary immune response in vivo","volume":"106","author":"Callan","year":"2000","journal-title":"J Clin Invest"},{"key":"B8","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1002\/jmv.1890280211","article-title":"Brief report: killer cell defect and persistent immunological abnormalities in two patients with chronic active Epstein-Barr virus infection","volume":"28","author":"Joncas","year":"1989","journal-title":"J Med Virol"},{"key":"B9","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1111\/j.1442-200X.1993.tb03079.x","article-title":"Defective activity of Epstein-Barr virus (EBV) specific cytotoxic T lymphocytes in children with chronic active EBV infection and in their parents","volume":"35","author":"Fujieda","year":"1993","journal-title":"Acta Paediatr Jpn"},{"key":"B10","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1086\/423285","article-title":"Quantitative analysis of Epstein-Barr virus (EBV)-specific CD8+ T cells in patients with chronic active EBV infection","volume":"190","author":"Sugaya","year":"2004","journal-title":"J Infect Dis"},{"key":"B11","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1002\/jmv.1029","article-title":"Impaired cytotoxic T lymphocyte response to Epstein-Barr virus-infected NK cells in patients with severe chronic active EBV infection","volume":"64","author":"Tsuge","year":"2001","journal-title":"J Med Virol"},{"key":"B12","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1007\/BF00221388","article-title":"Intact antigen presentation for Epstein-Barr virus (EBV)-specific CTL by a lymphoblastoid cell line established from a patient with severe chronic active EBV infection","volume":"184","author":"Kimura","year":"1995","journal-title":"Med Microbiol Immunol"},{"key":"B13","doi-asserted-by":"publisher","first-page":"387","DOI":"10.3109\/1547691X.2012.758199","article-title":"Clinical significance of variations in levels of Epstein-Barr virus (EBV) antigen and adaptive immune response during chronic active EBV infection in children","volume":"10","author":"Xing","year":"2013","journal-title":"J Immunotoxicol"},{"key":"B14","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1007\/s00277-016-2911-8","article-title":"Comprehensive assessment of peripheral blood TCR\u03b2 repertoire in infectious mononucleosis and chronic active EBV infection patients","volume":"96","author":"Liu","year":"2017","journal-title":"Ann Hematol"},{"key":"B15","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1002\/rmv.505","article-title":"Pathogenesis of chronic active Epstein-Barr virus infection: is this an infectious disease, lymphoproliferative disorder, or immunodeficiency?","volume":"16","author":"Kimura","year":"2006","journal-title":"Rev Med Virol"},{"key":"B16","doi-asserted-by":"publisher","first-page":"5835","DOI":"10.1182\/blood-2010-11-316745","article-title":"Characterization and treatment of chronic active Epstein-Barr virus disease: a 28-year experience in the United States","volume":"117","author":"Cohen","year":"2011","journal-title":"Blood"},{"key":"B17","first-page":"355","article-title":"EBV-positive T-cell and NK-cell lymphoproliferative diseases of childhood","volume-title":"WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues","author":"Quintanilla-Martinez","year":"2017"},{"key":"B18","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1002\/ajh.20398","article-title":"Proposed guidelines for diagnosing chronic active Epstein-Barr virus infection","volume":"80","author":"Okano","year":"2005","journal-title":"Am J Hematol"},{"key":"B19","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1007\/s12185-011-0831-x","article-title":"Clinical features of adult-onset chronic active Epstein-Barr virus infection: a retrospective analysis","volume":"93","author":"Arai","year":"2011","journal-title":"Int J Hematol"},{"key":"B20","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1086\/367988","article-title":"Prognostic factors for chronic active Epstein-Barr virus infection","volume":"187","author":"Kimura","year":"2003","journal-title":"J Infect Dis"},{"key":"B21","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1038\/modpathol.3800369","article-title":"Distribution and phenotype of Epstein-Barr virus-infected cells in human pharyngeal tonsils","volume":"18","author":"Hudnall","year":"2005","journal-title":"Mod Pathol"},{"key":"B22","doi-asserted-by":"publisher","first-page":"1323","DOI":"10.1086\/508197","article-title":"Epstein-Barr virus infects B and non-B lymphocytes in HIV-1-infected children and adolescents","volume":"194","author":"Bekker","year":"2006","journal-title":"J Infect Dis"},{"key":"B23","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/S0065-230X(08)60319-X","article-title":"The association of Epstein-Barr virus (EBV) with T-cell lymphoproliferations and Hodgkin\u2019s disease: two new developments in the EBV field","volume":"62","author":"Pallesen","year":"1993","journal-title":"Adv Cancer Res"},{"key":"B24","doi-asserted-by":"publisher","first-page":"4546","DOI":"10.1182\/blood-2010-05-285452","article-title":"Detection of EBV genomes in plasmablasts\/plasma cells and non-B cells in the blood of most patients with EBV lymphoproliferative disorders by using immuno-FISH","volume":"116","author":"Calattini","year":"2010","journal-title":"Blood"},{"key":"B25","first-page":"1898","article-title":"Epstein-Barr virus","volume-title":"Fields Virology","author":"Longnecker","year":"2013"},{"key":"B26","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1099\/vir.0.013482-0","article-title":"Quantitative analysis of Epstein-Barr virus (EBV)-related gene expression in patients with chronic active EBV infection","volume":"91","author":"Iwata","year":"2010","journal-title":"J Gen Virol"},{"key":"B27","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1086\/427239","article-title":"Differences between T cell-type and natural killer cell-type chronic active Epstein-Barr virus infection","volume":"191","author":"Kimura","year":"2005","journal-title":"J Infect Dis"},{"key":"B28","doi-asserted-by":"publisher","first-page":"2385","DOI":"10.1099\/0022-1317-82-10-2385","article-title":"Heterogeneous, restricted patterns of Epstein-Barr virus (EBV) latent gene expression in patients with chronic active EBV infection","volume":"82","author":"Yoshioka","year":"2001","journal-title":"J Gen Virol"},{"key":"B29","doi-asserted-by":"publisher","first-page":"2683","DOI":"10.1080\/10428194.2017.1304762","article-title":"Gene expression analysis of hypersensitivity to mosquito bite, chronic active EBV infection and NK\/T-lymphoma\/leukemia","volume":"58","author":"Washio","year":"2017","journal-title":"Leuk Lymphoma"},{"key":"B30","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1086\/317653","article-title":"Epstein-Barr virus (EBV) load and cytokine gene expression in activated T cells of chronic active EBV infection","volume":"183","author":"Ohga","year":"2001","journal-title":"J Infect Dis"},{"key":"B31","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1093\/infdis\/jit222","article-title":"Plasma viral microRNA profiles reveal potential biomarkers for chronic active Epstein-Barr virus infection","volume":"208","author":"Kawano","year":"2013","journal-title":"J Infect Dis"},{"key":"B32","first-page":"1249","article-title":"Lytic, nontransforming Epstein-Barr virus (EBV) from a patient with chronic active EBV infection","volume":"131","author":"Alfieri","year":"1984","journal-title":"Can Med Assoc J"},{"key":"B33","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1086\/598645","article-title":"A case of severe chronic active infection with Epstein-Barr virus: immunologic deficiencies associated with a lytic virus strain","volume":"29","author":"Schwarzmann","year":"1999","journal-title":"Clin Infect Dis"},{"key":"B34","doi-asserted-by":"publisher","first-page":"636","DOI":"10.7326\/0003-4819-104-5-636","article-title":"Chronic Epstein-Barr virus infection associated with fever and interstitial pneumonitis. Clinical and serologic features and response to antiviral chemotherapy","volume":"104","author":"Schooley","year":"1986","journal-title":"Ann Intern Med"},{"key":"B35","doi-asserted-by":"crossref","first-page":"3306","DOI":"10.1128\/JVI.61.10.3306-3309.1987","article-title":"Biomolecular analysis of a defective nontransforming Epstein-Barr virus (EBV) from a patient with chronic active EBV infection","volume":"61","author":"Alfieri","year":"1987","journal-title":"J Virol"},{"key":"B36","first-page":"280","article-title":"A familial syndrome of susceptibility to chronic active Epstein-Barr virus infection","volume":"130","author":"Joncas","year":"1984","journal-title":"Can Med Assoc J"},{"key":"B37","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1182\/blood-2011-10-381921","article-title":"EBV-associated T\/NK-cell lymphoproliferative diseases in nonimmunocompromised hosts: prospective analysis of 108 cases","volume":"119","author":"Kimura","year":"2012","journal-title":"Blood"},{"key":"B38","doi-asserted-by":"publisher","first-page":"1244","DOI":"10.1182\/blood-2003-06-2171","article-title":"Chronic active Epstein-Barr virus infection associated with mutations in perforin that impair its maturation","volume":"103","author":"Katano","year":"2004","journal-title":"Blood"},{"key":"B39","doi-asserted-by":"publisher","first-page":"2080","DOI":"10.3324\/haematol.2010.029389","article-title":"Atypical familial hemophagocytic lymphohistiocytosis due to mutations in UNC13D and STXBP2 overlaps with primary immunodeficiency diseases","volume":"95","author":"Rohr","year":"2010","journal-title":"Haematologica"},{"key":"B40","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1007\/s10875-015-0168-y","article-title":"Late-onset severe chronic active EBV in a patient for five years with mutations in STXBP2 (MUNC18-2) and PRF1 (perforin 1)","volume":"35","author":"Cohen","year":"2015","journal-title":"J Clin Immunol"},{"key":"B41","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1038\/ni.2771","article-title":"Dominant-activating germline mutations in the gene encoding the PI(3)K catalytic subunit p110\u03b4 result in T cell senescence and human immunodeficiency","volume":"15","author":"Lucas","year":"2014","journal-title":"Nat Immunol"},{"key":"B42","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1038\/nature10246","article-title":"Second messenger role for Mg2+ revealed by human T-cell immunodeficiency","volume":"475","author":"Li","year":"2011","journal-title":"Nature"},{"key":"B43","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1093\/cid\/ciw160","article-title":"Association of GATA2 deficiency with severe primary Epstein-Barr virus (EBV) infection and EBV-associated cancers","volume":"63","author":"Cohen","year":"2016","journal-title":"Clin Infect Dis"},{"key":"B44","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1007\/s10875-016-0332-z","article-title":"CTP synthase 1 deficiency in successfully transplanted siblings with combined immune deficiency and chronic active EBV infection","volume":"36","author":"Kucuk","year":"2016","journal-title":"J Clin Immunol"},{"key":"B45","first-page":"114","article-title":"Comprehensive genetic study of chronic active EBV infection","author":"Okuno","year":"2016"},{"key":"B46","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1038\/ng.3358","article-title":"Exome sequencing identifies somatic mutations of DDX3X in natural killer\/T-cell lymphoma","volume":"47","author":"Jiang","year":"2015","journal-title":"Nat Genet"},{"key":"B47","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1038\/nature11378","article-title":"Burkitt lymphoma pathogenesis and therapeutic targets from structural and functional genomics","volume":"490","author":"Schmitz","year":"2012","journal-title":"Nature"},{"key":"B48","unstructured":"HLA-A*26 and HLA-B*52 are associated with a risk of developing EBV-associated T\/NK lymphoproliferative disease ItoY SuzukiR ToriiY KawaK KikutaA KojimaS Blood2013"},{"key":"B49","doi-asserted-by":"publisher","first-page":"1780","DOI":"10.1093\/jnci\/94.23.1780","article-title":"Association of HLA class I and II alleles and extended haplotypes with nasopharyngeal carcinoma in Taiwan","volume":"94","author":"Hildesheim","year":"2002","journal-title":"J Natl Cancer Inst"},{"key":"B50","doi-asserted-by":"publisher","first-page":"3310","DOI":"10.1182\/blood-2007-05-086934","article-title":"HLA-A*02 is associated with a reduced risk and HLA-A*01 with an increased risk of developing EBV+ Hodgkin lymphoma","volume":"110","author":"Niens","year":"2007","journal-title":"Blood"},{"key":"B51","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1046\/j.1365-2559.1997.2880887.x","article-title":"Nasal T\/NK cell lymphomas commonly express perforin and Fas ligand: important mediators of tissue damage","volume":"31","author":"Ohshima","year":"1997","journal-title":"Histopathology"},{"key":"B52","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1182\/blood.V96.2.443","article-title":"Fulminant EBV(+) T-cell lymphoproliferative disorder following acute\/chronic EBV infection: a distinct clinicopathologic syndrome","volume":"96","author":"Quintanilla-Martinez","year":"2000","journal-title":"Blood"},{"key":"B53","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/S1040-8428(02)00118-X","article-title":"Overview and problematic standpoints of severe chronic active Epstein-Barr virus infection syndrome","volume":"44","author":"Okano","year":"2002","journal-title":"Crit Rev Oncol Hematol"},{"key":"B54","doi-asserted-by":"publisher","first-page":"1525","DOI":"10.1086\/587671","article-title":"Clinical and virological characteristics of 15 patients with chronic active Epstein-Barr virus infection treated with hematopoietic stem cell transplantation","volume":"46","author":"Gotoh","year":"2008","journal-title":"Clin Infect Dis"},{"key":"B55","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1038\/bmt.2010.122","article-title":"Excellent outcome of allogeneic hematopoietic SCT with reduced-intensity conditioning for the treatment of chronic active EBV infection","volume":"46","author":"Kawa","year":"2011","journal-title":"Bone Marrow Transplant"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"http:\/\/journal.frontiersin.org\/article\/10.3389\/fimmu.2017.01867\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,10,24]],"date-time":"2020-10-24T18:40:04Z","timestamp":1603564804000},"score":1,"resource":{"primary":{"URL":"http:\/\/journal.frontiersin.org\/article\/10.3389\/fimmu.2017.01867\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,12,22]]},"references-count":55,"alternative-id":["10.3389\/fimmu.2017.01867"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2017.01867","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,12,22]]},"article-number":"1867"}}